Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders

Introduction

HE4 is a novel biomarker for ovarian cancer. This study measured HE4 and CA125 levels in women with benign gynecologic disorders.

Serum Levels of the Ovarian Cancer Biomarker HE4 are decreased in Pregnancy and Increase with Age

Objectives:

To establish normal ranges for HE4 serum levels in healthy women.